Trade Summary

5 days ago, Pham Quang X, serving as Chairman, CEO and Interim CFO at Cadrenal Therapeutics, Inc. (CVKD), sold 18,124 shares at $3.88 per share, for a total transaction value of $70,351.96. Following this transaction, Pham Quang X now holds 132,715 shares of CVKD.

This sale represents a 12.02% decrease in Pham Quang X's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 11, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 16, 2026 (accepted Jun 15, 8:58 PM ET), 5 days after the trade was made.

Cadrenal Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.